Positive correlations between plasma BPI level and MPO-DNA and S100A8/A9 in myocardial infarction

References

• Wolf D, Ley K. Immunity and Inflammation in Atherosclerosis. Circ Res. 2019;124(2)::315–327. doi:10.1161/CIRCRESAHA.118.313591
   PubMedGoogle Scholar
• Crea F, Libby P. Acute Coronary Syndromes: the Way Forward From Mechanisms to Precision Treatment. Circulation. 2017;136(12)::1155–1166. doi:10.1161/CIRCULATIONAHA.117.029870
   PubMedGoogle Scholar
• Libby P. Inflammation in atherosclerosis. Nature 2002. 420 6917 868–874 10.1038/nature01323
   PubMed Web of Science ®Google Scholar
• Linge P, Fortin PR, Lood C, Bengtsson AA, Boilard E. The non-haemostatic role of platelets in systemic lupus erythematosus. Nat Rev Rheumatol. 2018;14::195–213.
   PubMed Web of Science ®Google Scholar
• Shrestha S, Lee JM, Hong CW. Autophagy in neutrophils. Korean J Physiol Pharmacol. 2020;24(1)::1–10. doi:10.4196/kjpp.2020.24.1.1
   PubMedGoogle Scholar
• Park SY, Shrestha S, Youn YJ, Kim JK, Kim SY, Kim HJ, Park SH, Ahn WG, Kim S, Lee MG. Autophagy Primes Neutrophils for Neutrophil Extracellular Trap Formation During Sepsis. Am J Respir Crit Care Med. 2017;196(5):577–589. doi:10.1164/rccm.201603-0596OC
   PubMed Web of Science ®Google Scholar
• Wang S, Rui S, Wang Z, Jing Z, Wang S, Jian M. S100A8/A9 in inflammation. Front Immunol. 2018;9:1298. doi:10.3389/fimmu.2018.01298
   PubMed Web of Science ®Google Scholar
• Baldrighi M, Mallat Z, Li X. NLRP3 inflammasome pathways in atherosclerosis. Atherosclerosis. 2017;267::127–138. doi:10.1016/j.atherosclerosis.2017.10.027
   PubMedGoogle Scholar
• Soehnlein O, Steffens S, Hidalgo A, Weber C. Neutrophils as protagonists and targets in chronic inflammation. Nat Rev Immunol. 2017;17(4)::248–261. doi:10.1038/nri.2017.10
   PubMedGoogle Scholar
• Nagareddy PR, Sreejit G, Abo-Aly M, Jaggers RM, Murphy AJ. NETosis Is Required for S100A8/A9-Induced Granulopoiesis After Myocardial Infarction. Arterioscler Thromb Vasc Biol. 2020;40(11)::2805–2807. doi:10.1161/ATVBAHA.120.314807
   PubMedGoogle Scholar
• Carestia A, Kaufman T, Rivadeneyra L, Landoni VI, Pozner RG, Negrotto S, D’Atri LP, Gómez RM, Schattner M. Mediators and molecular pathways involved in the regulation of neutrophil extracellular trap formation mediated by activated platelets. J Leukoc Biol. 2016;99(1):153-162.
   Web of Science ®Google Scholar
• Hang Y, Helena BM, Markus BJ, Yi L, Yi Z, Martin H. New Insights into Neutrophil Extracellular Traps: mechanisms of Formation and Role in Inflammation. Front Immunol. 2016;7:302.
   Web of Science ®Google Scholar
• Hofbauer TM, Mangold A, Scherz T, Seidl V, Panzenböck A, Ondracek AS, Müller J, Schneider M, Binder T, Hell L, et al. Neutrophil extracellular traps and fibrocytes in ST-segment elevation myocardial infarction. Basic Res Cardiol. 2019;114(5):33.doi:10.1007/s00395-019-0740-3
   PubMedGoogle Scholar
• Pertiwi KR, van der Wal AC, Pabittei DR, Mackaaij C, van Leeuwen MB, Li X, de Boer OJ. Neutrophil Extracellular Traps Participate in All Different Types of Thrombotic and Haemorrhagic Complications of Coronary Atherosclerosis. Thromb Haemost. 2018;118(6)::1078–1087. doi:10.1055/s-0038-1641749
   Google Scholar
• Döring Y, Libby P, Soehnlein O. Neutrophil Extracellular Traps Participate in Cardiovascular Diseases: recent Experimental and Clinical Insights. Circ Res. 2020;126(9)::1228–1241. doi:10.1161/CIRCRESAHA.120.315931
   Google Scholar
• Borissoff JI, Joosen IA, Versteylen MO, Brill A, Fuchs TA, Savchenko AS, Gallant M, Martinod K, Ten CH, Hofstra L. Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state. Arterioscler Thromb Vasc Biol. 2013;33(8)::2032–2040. doi:10.1161/ATVBAHA.113.301627
   PubMedGoogle Scholar
• Nakazawa D, Tomaru U, Yamamoto C, Jodo S, Ishizu A. Abundant neutrophil extracellular traps in thrombus of patient with microscopic polyangiitis. Front Immunol. 2012;3:333. doi:10.3389/fimmu.2012.00333
   PubMed Web of Science ®Google Scholar
• Estevez B, Du X. New Concepts and Mechanisms of Platelet Activation Signaling. Physiology. 2017;32(2):162. doi:10.1152/physiol.00020.2016
   PubMed Web of Science ®Google Scholar
• Jennifer Y, Wenjie L, Michael H, Isom LL. Platelet Signaling and Disease: targeted Therapy for Thrombosis and Other Related Diseases. Pharmacol Rev. 2018;70(3)::526–548. doi:10.1124/pr.117.014530
   Google Scholar
• Z L, K DM, A OBK. Signaling During Platelet Adhesion and Activation. Arterioscler Thromb Vasc Biol. 2010;30(12)::2341–2349. doi:10.1161/ATVBAHA.110.207522
   Google Scholar
• Carestia A, Kaufman T, Schattner M. Platelets: new Bricks in the Building of Neutrophil Extracellular Traps. Front Immunol. 2016;7. doi:10.3389/fimmu.2016.00271
   PubMed Web of Science ®Google Scholar
• Hwee LC, Adav SS, Kwan SS, Khai CY, Rathi S, Artur S. Thrombin and Plasmin Alter the Proteome of Neutrophil Extracellular Traps. Front Immunol. 2018;9:1554. doi:10.3389/fimmu.2018.01554
   PubMedGoogle Scholar
• Pircher J, Engelmann B, Massberg S, Schulz C. Platelet–Neutrophil Crosstalk in Atherothrombosis. Thromb Haemost. 2019;119(8):1274-1282.
   Web of Science ®Google Scholar
• Arjun B, Dipshikha C. Epithelial Cell Damage Activates Bactericidal/Permeability Increasing-Protein (BPI) Expression in Intestinal Epithelium. Front Microbiol. 2017;8:1567.
   Web of Science ®Google Scholar
• Levy O. A Neutrophil-Derived Anti-Infective Molecule: bactericidal/Permeability-Increasing Protein. Antimicrob Agents Chemother. 2000;44(11)::2925–2931. doi:10.1128/AAC.44.11.2925-2931.2000
   Google Scholar
• Schultz H, Weiss J. The bactericidal/permeability-increasing protein (bpi) in infection and inflammatory disease. Clinica Chimica Acta. 2007;384(1–2)::12–23. doi:10.1016/j.cca.2007.07.005
   PubMedGoogle Scholar
• Pinkenburg O, Meyer T, Bannert N, Norley S, Bolte K, Czudai-Matwich V, Herold S, Gessner A, Schnare M. The Human Antimicrobial Protein Bactericidal/Permeability-Increasing Protein (BPI) Inhibits the Infectivity of Influenza A Virus. PLoS ONE. 2016;11(6):e0156929. doi:10.1371/journal.pone.0156929
   PubMedGoogle Scholar
• Balakrishnan A, Marathe SA, Joglekar M, Chakravortty D. Bactericidal/permeability increasing protein: a multifaceted protein with functions beyond LPS neutralization. Innate Immun. 2013;19(4)::339–347. doi:10.1177/1753425912465098
   PubMedGoogle Scholar
• Takeda S, Watanabe-Kusunoki K, Nakazawa D, Kusunoki Y, Nishio S, Atsumi T. The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis. Front Immunol. 2019;10:1334. doi:10.3389/fimmu.2019.01334
   PubMedGoogle Scholar
• Iwuji K, Larumbe-Zabala E, Bijlani S, Nugent K, Kanu A, Manning E, Solis X. Prevalence of Bactericidal/Permeability-Increasing Protein Autoantibodies in Cystic Fibrosis Patients: systematic Review and Meta-Analysis. Pediatr Allergy Immunol Pulmonol. 2019;32(2)::45–51. doi:10.1089/ped.2018.0970
   PubMedGoogle Scholar
• Stoffel MP, Csernok E, Herzberg C, Johnson T, Carroll SF, Gross WL. Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders. Clin Exp Immunol. 2010;104(1)::54–59. doi:10.1046/j.1365-2249.1996.d01-654.x
   Google Scholar
• Walmsley RS, Zhao MH, Hamilton MI, Brownlee A, Chapman P, Pounder RE, Wakefield AJ, Lockwood CM. Antineutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease. Gut. 1997;40(1)::105–109. doi:10.1136/gut.40.1.105
   PubMedGoogle Scholar
• Schultz H. Sim: BPI-ANCA is found in reactive arthritis caused by Yersinia and Salmonella infection and recognise exclusively the C-terminal part of the BPI molecule. Scand J Rheumatol. 2000;29(4)::226–231. doi:10.1080/030097400750041361
   PubMedGoogle Scholar
• Chen CZ, Ou CY, Wang RH, Lee CH, Lin CC, Chang HY, Hsiue TR. The Role of Bactericidal/Permeability-Increasing Protein in Men with Chronic Obstructive Pulmonary Disease. Copd Journal of Chronic Obstructive Pulmonary Disease. 2012;9(2)::197–202. doi:10.3109/15412555.2011.654143
   Google Scholar
• Chen X, Qiu C. Serum BPI as a novel biomarker in asthma. Allergy Asthma & Clinical Immunology. 2020;16:50.
   Web of Science ®Google Scholar
• Levy O. Therapeutic potential of the bactericidal/permeability-increasing protein. Expert Opin Investig Drugs. 2002;11(2)::159–167. doi:10.1517/13543784.11.2.159
   PubMedGoogle Scholar
• Alva V, Lupas AN. The TULIP superfamily of eukaryotic lipid-binding proteins as a mediator of lipid sensing and transport. Biochimica Et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2016. 1861 8 913–923 10.1016/j.bbalip.2016.01.016
   PubMedGoogle Scholar
• Gubern C, Vendrell J, Ricart W, FernáNdezreal JM. Natural Antibiotics and Insulin Sensitivity The Role of Bactericidal/Permeability-Increasing Protein. Diabetes. 2006;55(1):216. doi:10.2337/diabetes.55.01.06.db05-1108
   PubMedGoogle Scholar
• Esteve E, Castro A, Moreno JM, Vendrell J, Ricart W, Fernández-Real J. Circulating bactericidal/permeability-increasing protein (BPI) is associated with serum lipids and endothelial function. Thromb Haemost. 2010;103(4)::780–787. doi:10.1160/TH09-08-0596
   PubMedGoogle Scholar
• Schaft D, Toebes EAH, Haseman JR, Mayo KH, Griffioen AW. Bactericidal/permeability-increasing protein (BPI) inhibits angiogenesis via induction of apoptosis in vascular endothelial cells. Blood. 2000;96(1)::176–181. doi:10.1182/blood.V96.1.176
   PubMedGoogle Scholar
• Eicher JD, Wakabayashi Y, Vitseva O, Esa N, Yang Y, Zhu J, Freedman JE, McManus DD, Johnson AD. Characterization of the platelet transcriptome by RNA sequencing in patients with acute myocardial infarction. Platelets. 2016;27(3)::230–239. doi:10.3109/09537104.2015.1083543
   PubMedGoogle Scholar
• Manesh R, Patel J, lhoon C H, Gregory J, Dehmer J. ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes: a Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoraci. J Am Coll Cardiol. 2017;24(2):439-463.
   Google Scholar
• Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. American Journal of Cardiology. 1983;51(3): 606–606. doi:10.1016/S0002-9149(83)80105-2
   Google Scholar
• Rampidis GP, Benetos G, Benz DC, Giannopoulos AA, Buechel RR. A guide for Gensini Score calculation. Atherosclerosis. 2019;287::181–183. doi:10.1016/j.atherosclerosis.2019.05.012
   PubMedGoogle Scholar
• Rada B. Neutrophil Extracellular Traps. Methods Mol Biol. 2019;1982::517–528.
   PubMedGoogle Scholar
• Kessenbrock K, Krumbholz M, Schönermarck U, Back W, Gross WL, Werb Z, Gröne HJ, Brinkmann V, Jenne DE. Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med. 2009;15(6)::623–625. doi:10.1038/nm.1959
   PubMedGoogle Scholar
• Ridker PM. From C-Reactive Protein to Interleukin-6 to Interleukin-1: moving Upstream To Identify Novel Targets for Atheroprotection. Circ Res 2016. 118 1 145–156 10.1161/CIRCRESAHA.115.306656
   PubMed Web of Science ®Google Scholar
• Mcdonald B , Davis R P , Kim S J , et al. Platelets and neutrophil extracellular traps collaborate to promote intravascular coagulation during sepsis in mice[J]. Blood, 2017, 129(10).
   Google Scholar
• Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD Jr., Wrobleski SK, Wakefield TW, Hartwig JH, Wagner DD. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A. 2010;107::15880–15885.
   Web of Science ®Google Scholar
• Silvain J, Collet JP, Nagaswami C, Beygui F, Edmondson KE, Bellemain-Appaix A, Cayla G, Pena A, Brugier D, Barthelemy O, et al. Composition of coronary thrombus in acute myocardial infarction. J Am Coll Cardiol. 2011;57(12)::1359–1367.doi:10.1016/j.jacc.2010.09.077
   PubMedGoogle Scholar
• Cui M, Fan M, Jing R, Wang H, Qin J, Sheng H, Wang Y, Wu X, Zhang L, Zhu J, et al. Cell-Free circulating DNA: a new biomarker for the acute coronary syndrome. Cardiology. 2013;124(2)::76–84.doi:10.1159/000345855
   PubMedGoogle Scholar
• Helseth R, Shetelig C, Andersen G, Langseth MS, Limalanathan S, Opstad TB, Arnesen H, Hoffmann P, Eritsland J, Seljeflot I. Neutrophil Extracellular Trap Components Associate with Infarct Size, Ventricular Function, and Clinical Outcome in STEMI. Mediators Inflamm. 2019;2019:7816491. doi:10.1155/2019/7816491
   PubMed Web of Science ®Google Scholar
• Jiménez-Alcázar M, Kim N, Fuchs T. Circulating Extracellular DNA: cause or Consequence of Thrombosis? Semin Thromb Hemost. 2017;43(6):553–561. doi:10.1055/s-0036-1597284
   PubMedGoogle Scholar
• Demyanets S, Stojkovic S, Mauracher LM, Kopp CW, Wojta J, Thaler J, Panzer S, Gremmel T. Surrogate Markers of Neutrophil Extracellular Trap Formation are Associated with Ischemic Outcomes and Platelet Activation after Peripheral Angioplasty and Stenting. J Clin Med. 2020;9(2):304.
   Web of Science ®Google Scholar
• Urban CFED, Schmid M. Neutrophil Extracellular Traps Contain Calprotectin, a Cytosolic Protein Complex Involved in Host Defense against Candida albicans. PLoS Pathog 2009, 5. 10 e1000639 10.1371/journal.ppat.1000639
   PubMed Web of Science ®Google Scholar
• Wang S, Song R, Wang Z, Jing Z, Wang S, Ma J. S100A8/A9 in Inflammation. Front Immunol. 2018;9:1298. doi:10.3389/fimmu.2018.01298
   PubMed Web of Science ®Google Scholar
• Stakos DA, Kambas K, Konstantinidis T, Mitroulis I, Apostolidou E, Arelaki S, Tsironidou V, Giatromanolaki A, Skendros P, Konstantinides S, et al. Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction. Eur Heart J. 2015;36(22)::1405–1414.doi:10.1093/eurheartj/ehv007
   PubMedGoogle Scholar
• Santilli F, Paloscia L, Liani R, Nicola MD, Marco MD, Lattanzio S, La Barba S, Pascale S, Mascellanti M, Davi G. Circulating Myeloid‐Related Protein–8/14 is Related to Thromboxane‐Dependent Platelet Activation in Patients With Acute Coronary Syndrome, With and Without Ongoing Low‐Dose Aspirin Treatment. Journal of the American Heart Association,3,4(2014-07-18). 2014;3:760.
   Web of Science ®Google Scholar
• Cotoi OS, Dunér P, Ko N, Hedblad B, Nilsson J, Björkbacka H, Schiopu A. Plasma S100A8/A9 correlates with blood neutrophil counts, traditional risk factors, and cardiovascular disease in middle-aged healthy individuals. Arterioscler Thromb Vasc Biol. 2014;34(1)::202–210. doi:10.1161/ATVBAHA.113.302432
   PubMedGoogle Scholar
• Katashima T, Naruko T, Terasaki F, Fujita M, Otsuka K, Murakami S, Sato A, Hiroe M, Ikura Y, Ueda M, et al. Enhanced expression of the S100A8/A9 complex in acute myocardial infarction patients. Circ J. 2010;74(4)::741–748.doi:10.1253/circj.CJ-09-0564
   PubMedGoogle Scholar
• Miyamoto S, Ueda M, Ikemoto M, Naruko T, Itoh A, Tamaki S, Nohara R, Terasaki F, Sasayama S, Fujita M. Increased serum levels and expression of S100A8/A9 complex in infiltrated neutrophils in atherosclerotic plaque of unstable angina. Heart. 2008;94(8)::1002–1007. doi:10.1136/hrt.2007.121640
   Google Scholar
• Zeller TSM, Müller C, Scholz M, Schäffer A, Ojeda F, Drexel H, Mündlein A, ME K, März W, Sinning C, et al. Genome-Wide Association Analysis for Severity of Coronary Artery Disease Using the Gensini Scoring System. Front Cardiovasc Med. 2017Sep;20:57. doi:10.3389/fcvm.2017.00057
   Google Scholar